The management of the clinically positive neck as part of a larynx preservation approach. 1993

J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
Department of Radiation Oncology, Brachytherapy Service, Memorial Sloan-Kettering Cancer Center, NYC, NY 10021.

OBJECTIVE For patients with squamous cell carcinoma of the head and neck with palpable neck node metastases, the standard management of the neck usually involves neck dissection and postoperative neck irradiation. A strategy of larynx preservation with induction chemotherapy and radiation therapy has been utilized for patients with locally advanced resectable cancer of the larynx, hypopharynx, and oropharynx. For patients treated in this non-surgical manner for the primary site, the optimal management of the clinically positive neck has not been clarified. To determine whether response to induction chemotherapy could help to select patients in whom neck dissection could be omitted in favor of definitive radiation therapy alone, we have analyzed our prospective larynx preservation experience. METHODS Between 1983-1989, 80 patients were entered onto larynx preservation protocols involving 1-3 cycles of cisplatin based chemotherapy followed by radiation therapy with or without neck dissection. There were 54 patients with clinically positive necks to treatment, of whom 44% (24/54) had a complete response, and of whom 20% (11/54) had a partial response to chemotherapy in the neck. In 22 of these 35 patients with clinically positive necks who achieved a major neck response to chemotherapy, radiation therapy (median 66 Gy) was used as the only subsequent treatment of the neck. RESULTS At a median follow-up of 25 months (range 7-83 months), neck control for this subset is 91% (20/22). Neck failure occurred in 20% (1/5) of patients with a partial response to chemotherapy treated without neck dissection and 6% (1/17) of node positive with a complete response. CONCLUSIONS These results suggest that patients with clinically palpable cervical nodal metastases who have a complete response to chemotherapy and receive high dose radiation therapy have excellent neck control and may not need neck dissection. Further experience will be required to confirm these preliminary data and to determine if patients who achieve a partial response in the neck after induction chemotherapy can be treated with radiation therapy without neck dissection.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
November 1998, American journal of surgery,
J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
November 1994, American journal of surgery,
J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
August 2002, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology,
J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
January 2020, The breast journal,
J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
January 2005, Cancer journal (Sudbury, Mass.),
J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
January 2002, Current oncology reports,
J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
September 1999, The Annals of otology, rhinology, and laryngology,
J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
January 1991, Important advances in oncology,
J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
September 2008, Head & neck,
J Armstrong, and D Pfister, and E Strong, and R Heimann, and D Kraus, and A Polishook, and M Zelefsky, and G Bosl, and J Shah, and R Spiro
May 1988, La Radiologia medica,
Copied contents to your clipboard!